These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8052756)

  • 41. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High polymeric IgA content facilitates recognition of microbial polysaccharide-natural serum antibody immune complexes by immobilized human galectin-1.
    Paul A; Antony M; Mathai J; Appukuttan PS
    Immunol Lett; 2011 Apr; 136(1):55-60. PubMed ID: 21147166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of an IgA-depleted intravenous immunoglobulin in a patient with an anti-IgA antibody.
    Cunningham-Rundles C; Wong S; Björkander J; Hanson LA
    Clin Immunol Immunopathol; 1986 Feb; 38(2):141-9. PubMed ID: 3079685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.
    Franssen MJ; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1985 Nov; 44(11):766-71. PubMed ID: 4062389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A three-tiered view of the role of IgA in mucosal defense.
    Mazanec MB; Nedrud JG; Kaetzel CS; Lamm ME
    Immunol Today; 1993 Sep; 14(9):430-5. PubMed ID: 8216720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of ankylosing spondylitis with IgA-multiple myeloma: report of a case and pathogenetic considerations.
    Lam SM; Ho HH; Dunn P; Luo SF
    Taiwan Yi Xue Hui Za Zhi; 1989 Jul; 88(7):726-8. PubMed ID: 2809565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ankylosing spondylitis, IgA, and transforming growth factors.
    Archer JR
    Ann Rheum Dis; 1995 Jul; 54(7):544-6. PubMed ID: 7668896
    [No Abstract]   [Full Text] [Related]  

  • 49. IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis.
    Mäki-Ikola O; Nissilä M; Lehtinen K; Granfors K
    Br J Rheumatol; 1998 Dec; 37(12):1299-302. PubMed ID: 9973153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The significance of raised serum IgA in ankylosing spondylitis with IgA nephropathy.
    Chou CT; Lee CF; Shieh SD; Huang HW; Ho YS
    Taiwan Yi Xue Hui Za Zhi; 1984 Dec; 83(12):1232-7. PubMed ID: 6597853
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI-TLR Cross-Talk.
    Hansen IS; Hoepel W; Zaat SAJ; Baeten DLP; den Dunnen J
    J Immunol; 2017 Dec; 199(12):4124-4131. PubMed ID: 29118246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The IgA mucosal immune system.
    Lamm ME
    Am J Kidney Dis; 1988 Nov; 12(5):384-7. PubMed ID: 3055963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
    Vuento R; Eskola J; Leino R; Koskimies S; Viander M
    Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The pathogenesis of primary IgA-nephropathy].
    van den Wall Bake AW; Daha MR; van Es LA
    Tijdschr Kindergeneeskd; 1990 Apr; 58(2):55-9. PubMed ID: 2190351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of equine immunoglobulin A in serum and secretions by a fluorescent bead-based assay.
    Schnabel CL; Babasyan S; Freer H; Wagner B
    Vet Immunol Immunopathol; 2017 Jun; 188():12-20. PubMed ID: 28615123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IgA receptors in health and disease.
    Wines BD; Hogarth PM
    Tissue Antigens; 2006 Aug; 68(2):103-14. PubMed ID: 16866880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there IgA of gut mucosal origin in the serum of HIV1 infected patients?
    Quesnel A; Moja P; Lucht F; Touraine JL; Pozzetto B; Genin C
    Gut; 1994 Jun; 35(6):803-8. PubMed ID: 7517378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgA serum levels and disease activity in ankylosing spondylitis.
    Calabro JJ
    Ann Rheum Dis; 1987 Jan; 46(1):85. PubMed ID: 3813682
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies of circulating immune complexes in ankylosing spondylitis.
    Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
    Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High levels of IgA-containing circulating immune complex and secretory IgA in Kawasaki disease.
    Ohshio G; Furukawa F; Khine M; Yoshioka H; Kudo H; Hamashima Y
    Microbiol Immunol; 1987; 31(9):891-8. PubMed ID: 3696008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.